- Report
- March 2025
- 150 Pages
Global
From €4430EUR$4,850USD£3,788GBP
- Report
- August 2024
- 381 Pages
Global
From €4383EUR$4,799USD£3,748GBP
- Report
- November 2024
- 239 Pages
Global
From €3813EUR$4,175USD£3,261GBP
- Report
- April 2024
- 402 Pages
Global
From €4521EUR$4,950USD£3,866GBP
- Report
- October 2024
- 185 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- October 2024
- 184 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- March 2025
- 192 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- October 2024
- 180 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- October 2024
- 195 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- October 2024
- 198 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- October 2024
- 199 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- January 2025
- 153 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- August 2024
- 100 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- July 2024
- 180 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- April 2025
- 391 Pages
Global
From €5115EUR$5,600USD£4,374GBP
- Report
- April 2025
- 265 Pages
Global
From €5115EUR$5,600USD£4,374GBP
- Report
- April 2025
- 274 Pages
Global
From €5115EUR$5,600USD£4,374GBP
- Report
- April 2025
- 268 Pages
Global
From €4978EUR$5,450USD£4,257GBP
- Report
- April 2025
- 292 Pages
Global
From €5115EUR$5,600USD£4,374GBP
- Report
- March 2025
- 175 Pages
Global
From €4101EUR$4,490USD£3,507GBP

Toxoid vaccines are a type of vaccine that use a modified form of a toxin or toxin-producing microorganism to stimulate the body's immune system to produce antibodies against the toxin. The toxin is usually inactivated or weakened so that it does not cause disease, but still stimulates the body's immune system to produce antibodies. Toxoid vaccines are used to protect against a variety of diseases, including diphtheria, tetanus, and pertussis.
Toxoid vaccines are widely used in both developed and developing countries, and are an important part of routine immunization programs. They are also used in the prevention of certain occupational diseases, such as tetanus in healthcare workers.
The toxoid vaccine market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more